TP53 and colorectal carcinoma: To evaluate potentially deregulated biological processes underlying SMAD4 and FBXW7 mutations in the TP53–defficient CRC population, we analyzed WES and RNA–seq data from 533 colorectal tumors conforming the TCGA cohorts COAD and READ.